SOPH
SOPHIA GENETICS SA
SOPHIA GENETICS SA historical holders
total: 2
Akre Capital Management SOPHIA GENETICS SA transactions over time
- Total transactions:
- 4
- New positions:
- 1
- Added:
- 3
- Held since:
- 2024 Q1
- Held for:
- 9 quarters
- Latest activity:
- 2025 Q2
Chuck Akre has been an institutional investor in SOPHIA GENETICS SA (SOPH) since 2024 Q1. According to 2026 Q1 report, Chuck Akre holds 3,719,140 shares with a market value of roughly $18.41M representing 0.30% of their equity portfolio. The fund/company first acquired SOPH in 2024 Q1, initially purchasing 287,699 shares. Since the initial investment, Akre Capital Management has made 3 more transactions in this position.
Does Chuck Akre still hold SOPH?
Yes, Chuck Akre continues to hold SOPHIA GENETICS SA (SOPH). According to their 2026 Q1 report, they maintain a position of 3,719,140 shares valued at approximately $18.41M, representing 0.30% of their equity portfolio.
When did Chuck Akre first invest in SOPH?
Chuck Akre first invested in SOPHIA GENETICS SA (SOPH) in 2024 Q1 at the reported quarter-end price of $4.93 per share, acquiring 287,699 shares in their initial purchase.
What is Chuck Akre's average cost basis for SOPH?
Based on historical transaction data, Chuck Akre's estimated cost basis for SOPHIA GENETICS SA (SOPH) is approximately $3.94 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $3.94
SOPH transactions history by Akre Capital Management
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.11%
|
3,719,140
|
$3.10
|
$11,529,334
|
+66.22% (+1,481,636)
|
+0.04%
|
|
2024 Q3
|
0.07%
|
2,237,504
|
$3.65
|
$8,166,890
|
+16.51% (+317,072)
|
+0.01%
|
|
2024 Q2
|
0.08%
|
1,920,432
|
$4.58
|
$8,795,579
|
+567.51% (+1,632,733)
|
+0.07%
|
|
2024 Q1
|
0.01%
|
287,699
|
$4.93
|
$1,418,356
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.